GB9914960D0 - Delivery system - Google Patents

Delivery system

Info

Publication number
GB9914960D0
GB9914960D0 GBGB9914960.1A GB9914960A GB9914960D0 GB 9914960 D0 GB9914960 D0 GB 9914960D0 GB 9914960 A GB9914960 A GB 9914960A GB 9914960 D0 GB9914960 D0 GB 9914960D0
Authority
GB
United Kingdom
Prior art keywords
delivery system
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914960.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to GBGB9914960.1A priority Critical patent/GB9914960D0/en
Publication of GB9914960D0 publication Critical patent/GB9914960D0/en
Priority to JP2001506849A priority patent/JP2003503066A/en
Priority to CA002377534A priority patent/CA2377534A1/en
Priority to EP00942323A priority patent/EP1194576A1/en
Priority to PCT/IB2000/000974 priority patent/WO2001000857A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB9914960.1A 1999-06-25 1999-06-25 Delivery system Ceased GB9914960D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9914960.1A GB9914960D0 (en) 1999-06-25 1999-06-25 Delivery system
JP2001506849A JP2003503066A (en) 1999-06-25 2000-06-23 Delivery system
CA002377534A CA2377534A1 (en) 1999-06-25 2000-06-23 Delivery system
EP00942323A EP1194576A1 (en) 1999-06-25 2000-06-23 Delivery system
PCT/IB2000/000974 WO2001000857A1 (en) 1999-06-25 2000-06-23 Delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914960.1A GB9914960D0 (en) 1999-06-25 1999-06-25 Delivery system

Publications (1)

Publication Number Publication Date
GB9914960D0 true GB9914960D0 (en) 1999-08-25

Family

ID=10856119

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914960.1A Ceased GB9914960D0 (en) 1999-06-25 1999-06-25 Delivery system

Country Status (5)

Country Link
EP (1) EP1194576A1 (en)
JP (1) JP2003503066A (en)
CA (1) CA2377534A1 (en)
GB (1) GB9914960D0 (en)
WO (1) WO2001000857A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615506A1 (en) 2005-07-15 2007-01-25 Novartis Ag Pamps, pathogen associated molecular patterns
EP1767214B1 (en) * 2005-09-23 2009-05-13 Gianfranco Del Prete Use of neurotrophil activating protein of helicobacter pylori (HP-NAP) and/or of its portions as adjuvants for the development of T helper type 1 (TH1) immune responses
NZ574777A (en) 2006-08-09 2012-02-24 Univ Florida Re-engineering bacteria for ethanol production
CN109897813A (en) * 2019-03-21 2019-06-18 贵州医科大学 The construction method of helicobacter pylori cagA gene Inactivating mutations strain

Also Published As

Publication number Publication date
JP2003503066A (en) 2003-01-28
WO2001000857A1 (en) 2001-01-04
CA2377534A1 (en) 2001-01-04
EP1194576A1 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
HUP0300246A3 (en) Delivery system
EP1221148A4 (en) Tactiovisual distance-to-exit exit-finding system
EP1061987A4 (en) Drug delivery system
EP1098673A4 (en) Agent delivery systems
GB9904925D0 (en) Gas delivery system
EP1225941A4 (en) Intranasal delivery system
GB2347686B (en) Gas delivery system
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB9907271D0 (en) System
GB9914960D0 (en) Delivery system
GB0014898D0 (en) Delivery system
GB9918154D0 (en) Expression system
GB0003919D0 (en) Kinetomatic system III
GB9902234D0 (en) Expression system
GB2375831B (en) Ranging system
GB9911547D0 (en) Answerphone system
GB2337520B (en) Delivery system
GB9811152D0 (en) Delivery system
GB9925065D0 (en) Logistical delivery system
GB9905134D0 (en) Medicament delivery system
GB9923273D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB0001935D0 (en) Delivery system
GB0026332D0 (en) Delivery system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)